This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Gamel, J. W Articles by Vogel, R. L Search for Related Content PubMed PubMed Citation Articles by Gamel, J. W Articles by Vogel, R. L Social Bookmarking                         What's this?

Non-parametric comparison of relative versus cause-specific survival in Surveillance, Epidemiology and End Results (SEER) programme breast cancer patients

Veterans Administration Medical Center and University of Louisville School of Medicine, Louisville, Kentucky, USA, jgamel{at}louisville.edu

Robert L Vogel

Departments of Family Medicine and Community Medicine, Mercer University School of Medicine, Macon, Georgia, USA

Cancer-related mortality can be measured by two dissimilar methods: NAcause-specific survival (based on mortality attributed to a specific cause), and relative survival (based on mortality relative to a matched cohort). We used both methods to determine actuarial survival in a population of 119 502 breast cancer patients from the Surveillance, Epidemiology and End Results (SEER) programme data set, with 20 years of follow-up. The population was divided into four strata by patient age and tumour stage. In all strata, there was only minimal deviation between the two survival methods. Of particular interest was the cause-specific treatment of patients recorded as dead of unknown cause, i.e. those deaths that could not be attributed with certainty to either ‘breast cancer’ or to ‘other causes’. Findings suggest that the most reliable results may be obtained by apportioning these deaths between ‘dead of cause’ and ‘withdrawn at the time of death’. This apportionment is based on the relative number of deaths attributed to ‘breast cancer’ versus ‘other causes’.

Statistical Methods in Medical Research, Vol. 10, No. 5, 339-352 (2001)
DOI: 10.1177/096228020101000503


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				S. B. Clauser Use of Cancer Performance Measures in Population Health: A Macro-level Perspective J Natl Cancer Inst Monographs, October 1, 2004; 2004(33): 142 - 154. [Abstract] [Full Text] [PDF]